Resource

Letter to FDA Urging the Agency to Seize Adulterated Ginkgo Biloba Pills

ShareThis

Letter to Steven Tave, Director, Office of Dietary Supplement Programs at FDA

CSPI is calling on FDA to use its enforcement authority to seize adulterated ginkgo biloba pills in the marketplace. See the original press release.